Pinealon peptide: what the Russian research actually shows

Pinealon is a three-amino-acid peptide from Russia's bioregulator research programme. What its published studies measured, how it differs from Epithalon, and what is still unknown.

Published · Updated · 9 min read
TL;DR
  • Pinealon is a synthetic tripeptide (Glu-Asp-Arg, or EDR) developed by Vladimir Khavinson's group in St. Petersburg. It is not an approved medicine anywhere in the US or EU.
  • In cell culture, a 2011 study in Rejuvenation Research found it reduced oxidative stress and cell death in brain cells exposed to hydrogen peroxide.
  • Its proposed mechanism is gene regulation: short peptides of this kind are thought to change how tightly DNA is packed, which changes which genes are read.
  • Pinealon and Epithalon are different peptides with different proposed targets. Pinealon is studied for brain cell protection; Epithalon for telomerase.
  • No Western randomised controlled trial of Pinealon exists. The human evidence is small Russian studies that are hard to verify independently.

Pinealon is a three-amino-acid peptide that comes out of the Russian bioregulator research programme led by Vladimir Khavinson. It is studied mainly for protecting brain cells from oxidative stress, and it is often discussed alongside melatonin and the ageing pineal gland. Very little of this research has been tested outside Russia, and none of it in a Western randomised trial. Here is what has been published, and what that does and does not tell you.

In plain English

This page is education about the research record. It does not recommend using Pinealon. Pinealon is not an approved medicine in the US or EU.

The research

What is Pinealon, and what did the studies measure?

Pinealon is a synthetic tripeptide with the sequence Glu-Asp-Arg (EDR), developed at the St. Petersburg Institute of Bioregulation and Gerontology. At roughly 418 daltons it is small, and its developers propose that it can reach the cell nucleus, where it is thought to act.

The best-cited study is a cell culture experiment:

"Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes in cerebellar granule cell cultures exposed to hydrogen peroxide."

Khavinson V et al., Rejuvenation Research, 2011 (PMID 21978084)

That paper reported lower levels of reactive oxygen species and fewer cells undergoing programmed cell death, acting through a signalling pathway called ERK. It was done in cultured cells, not in people.

A 2022 paper by Ilina, Khavinson, Linkova and colleagues in the International Journal of Molecular Sciences examined how very short peptides, including the EDR sequence, may change gene activity by altering how tightly DNA is packed. That points to a proposed mechanism of gene regulation rather than a hormone docking into a receptor. Khavinson's group has also reported that Pinealon influences CREB and AANAT, genes involved in melatonin production; that work is preclinical.

What human data exists?

The human evidence is limited to small Russian clinical reports. One study of 72 people with traumatic brain injury reported improvements in working memory and headache measures when Pinealon was added to standard care. It was not a placebo-controlled trial in the Western sense, and its full methods are hard to verify from outside Russia.

No Western randomised controlled trial of Pinealon has been published, and no study has measured whether it changes melatonin levels in people.

0

Western randomised controlled trials of Pinealon published as of October 2026.

Pinealon vs Epithalon

How is Pinealon different from Epithalon?

Both peptides come from the same research programme and both are linked to the pineal gland, which is why they are often confused. They are different molecules with different proposed targets.

Epithalon (AEDG tetrapeptide)

Four amino acids: Ala-Glu-Asp-Gly. Studied mainly for activating telomerase, the enzyme that rebuilds the protective caps on the ends of chromosomes. See the Epithalon research summary.

Pinealon (EDR tripeptide)

Three amino acids: Glu-Asp-Arg. Studied mainly for protecting brain cells from oxidative stress in culture, and proposed to influence genes involved in melatonin production.

Pinealon (EDR) is also distinct from Vesugen (KED, Lys-Glu-Asp), another bioregulator from the same programme, which is studied for vascular tissue. The abbreviations look similar; the sequences are different.

The melatonin question

Does Pinealon restore melatonin?

That has not been shown in people. The context is real: melatonin output falls with age, and the pineal gland gathers calcium deposits over the lifespan. A review by Wu and Swaab in the Journal of Pineal Research (2005) documented the age-related decline and its link to pineal changes. But the claim that Pinealon reverses that decline rests on preclinical gene-expression work. No human study has measured melatonin before and after Pinealon, and no study has shown that it removes calcium deposits.

The genetics

What genetics research says about the body clock

Body-clock genes vary between people, and some of that variation has been linked to sleep timing and sleep quality in human studies. None has been tested as a predictor of response to Pinealon.

CLOCK sits at the centre of the body's master timekeeper. One common variant (rs1801260, also written T3111C) has been linked to an evening chronotype and more irregular sleep in studies published in Chronobiology International.

PER3 contains a repeated stretch of DNA that comes in a short (4-repeat) and long (5-repeat) form. Archer and colleagues, writing in Sleep in 2003, linked these forms to differences in sleep timing, and later work linked them to how strongly sleep loss affects thinking.

No study has tested whether either genotype changes response to Pinealon. A DNA report can show which versions you carry and what the sleep research found; no study has tested what those versions mean for this peptide.

Verdict: Pinealon has an interesting cell culture record and a proposed gene-regulation mechanism, almost all of it from one research group. The human evidence is small and hard to verify, no Western trial exists, and no study has measured its effect on melatonin in people. It is a research compound, not an established treatment for anything.

ShareXLinkedIn
Your DNA reportSee how your DNA reads the peptides in this guide.Your report reads the DNA file you already have against the published research on 31 peptides, marker by marker, and says what that research does and does not show. Checked by our team, ready within 24 hours.Upload your DNA, $99No DNA test yet? Order one →

Frequently asked questions

What is Pinealon?

Pinealon is a synthetic three-amino-acid peptide (Glu-Asp-Arg, or EDR) developed in Vladimir Khavinson's bioregulator research programme in St. Petersburg. It is studied mainly for protecting brain cells from oxidative stress. It is not an approved medicine in the US or EU.

What has Pinealon research actually shown?

In a 2011 cell culture study in Rejuvenation Research, Pinealon reduced oxidative stress and cell death in brain cells exposed to hydrogen peroxide. Small Russian clinical reports describe cognitive and headache improvements in people with brain injury, but no Western randomised controlled trial has been published.

What is the difference between Pinealon and Epithalon?

They are different peptides from the same research programme. Epithalon (Ala-Glu-Asp-Gly) is studied mainly for activating telomerase. Pinealon (Glu-Asp-Arg) is studied mainly for protecting brain cells from oxidative stress and is proposed to influence genes involved in melatonin production.

Does Pinealon increase melatonin?

That has not been shown in people. Preclinical work from Khavinson's group suggests it influences genes involved in melatonin production, but no human study has measured melatonin levels before and after Pinealon.

Is Pinealon safe?

Its safety has not been studied in a controlled trial. The Russian research programme has not published reports of serious adverse events, but absence of reported harm in small, uncontrolled studies is not evidence of safety.

Can genetics predict a response to Pinealon?

No study has tested that. Body-clock genes such as CLOCK and PER3 have been linked to sleep timing in human studies, but none has been tested as a predictor of response to Pinealon.

This article is for informational and educational purposes only. It reports what published research found; it is not medical advice, it does not diagnose, treat, cure or prevent any disease, and nothing in it is a dose or a recommendation to use any compound. Talk to a licensed clinician about any medical decision.

Keep reading

Related articles

Peptide GuidesEpithalon and telomere length: what 30 years of research shows, and what it does not10 min readPeptide GuidesPeptides studied for sleep: what the research on DSIP, Epithalon and ipamorelin measured8 min read
← PreviousThymulin: the thymus hormone that fades by 60, and what research says about itPeptide Guides · 9 min readNext →Cortagen peptide: 5 things most articles get wrongPeptide Guides · 9 min read
Upload your DNA